Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-azd-2_06-cv-00043/USCOURTS-azd-2_06-cv-00043-1/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1332 Diversity-Product Liability

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

WO

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF ARIZONA

Mayna Nix,

Plaintiff, 

v. 

GlaxoSmithKline PLC, et al.,

Defendants. _________________________________

)

)

)

)

)

)

)

)

)

)

No. CV-06-00043-PHX-SMM 

ORDER

Pending before the Court is a Motion for Reconsideration filed by Plaintiff Mayna Nix,

pursuant to Rule 59(e) of the Federal Rules of Civil Procedure. (Dkt. 153.) Plaintiff urges the

Court to reevaluate its September 5th Order (Dkt. 147), which granted Defendant

GlaxoSmithKline’s motion for summary judgment (Dkt. 105) and ordered this action be

terminated.

Local Rule of Civil Procedure 7.2(g) states “[n]o response to a motion for

reconsideration or clarification and no reply to the response shall be filed unless ordered by the

Court.” The Court finds a response by Defendants would assist the Court in deciding Plaintiff’s

motion for reconsideration. Accordingly,

IT IS HEREBY ORDERED that Defendants shall file a response to Plaintiff’s motion

for reconsideration by October 10, 2007.

//

//

//

Case 2:06-cv-00043-SMM Document 154 Filed 09/25/07 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 2 -

IT IS FURTHER ORDERED that Plaintiff shall have until October 17, 2007 to file

a reply to Defendants’ response, if Plaintiff so desires.

DATED this 25th day of September, 2007.

Case 2:06-cv-00043-SMM Document 154 Filed 09/25/07 Page 2 of 2